Skip to main content

When dry eye symptoms flare up, it's time to speak up

Make an appointment with your eye doctor today

It can be hard to remember all of the things you want to discuss with your eye doctor once you finally get to the appointment. The discussion guide below can help you talk about your dry eye symptom flare‑ups, and whether EYSUVIS might help.

Even if you aren’t experiencing a flare‑up right now, if you’ve had flares before, there’s a good chance you’ll face those symptoms again. So don’t wait, make an appointment to see if EYSUVIS could be right for you.

Use the guide below to help get the conversation started.

Download Discussion Guide

Start saving on your EYSUVIS prescription

Make sure you’re always ready for a flare‑up. 80% of patients who suffer from dry eye symptoms experience recurring flares. It might be helpful to make sure you have EYSUVIS on hand, because you never know when another flare‑up might strike.

SEE HOW YOU CAN SAVE

EYSUVIS® (loteprednol etabonate ophthalmic suspension) savings card

Contact us

For additional information or to report an adverse event, call Kala Pharmaceuticals, Inc. at 1‑833‑287‑KALA
(1‑833‑287‑5252).

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit , or call 1‑800‑FDA‑1088.

Sign up for updates

Want to know more about EYSUVIS? Register your email to get updates and information on the drop that’s there for the flare.

* In a clinical trial program with 2871 patients with dry eye, patients using EYSUVIS showed significant reduction in the symptoms of dry eye (ocular discomfort) as early as Day 4 after starting treatment (versus placebo). Symptoms continued to improve up to the end of the treatment period (Day 15). Patients taking EYSUVIS also showed significant reduction in signs of dry eye (eye redness) at Day 15 versus placebo.

2018 Lieberman Dry Eye Patient Survey (N=297).